S. Barondes, D. Cooper, M. Gitt, and H. Leffler, Structure and function of a large family of animal lectins, J Biol Chem, vol.269, pp.20807-20810, 1994.

K. Kasai and J. Hirabayashi, Galectins: A Family of Animal Lectins That Decipher Glycocodes, Journal of Biochemistry, vol.119, issue.1, pp.1-8, 1996.
DOI : 10.1093/oxfordjournals.jbchem.a021192

T. Magnaldo, D. Fowlis, and M. Darmon, Galectin-7, a marker of all types of stratified epithelia, Differentiation, vol.63, issue.3, pp.159-168, 1998.
DOI : 10.1046/j.1432-0436.1998.6330159.x

F. Bernerd, A. Sarasin, and T. Magnaldo, Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes, Proceedings of the National Academy of Sciences, vol.96, issue.20, pp.11329-11334, 1999.
DOI : 10.1073/pnas.96.20.11329

K. Polyak, Y. Xia, J. Zweier, K. Kinzler, and B. Vogelstein, A model for p53- induced apoptosis, Nature, vol.389, issue.6648, pp.300-305, 1997.
DOI : 10.1038/38525

J. Lu, H. Pei, M. Kaeck, and H. Thompson, Gene expression changes associated with chemically induced rat mammary carcinogenesis, Molecular Carcinogenesis, vol.19, issue.2, pp.204-215, 1997.
DOI : 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M

C. Perou, T. Sorlie, M. Eisen, M. Van-de-rijn, and S. Jeffrey, Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000.
DOI : 10.1038/35021093

C. Jones, A. Mackay, A. Grigoriadis, A. Cossu, and J. Reis-filho, Expression Profiling of Purified Normal Human Luminal and Myoepithelial Breast Cells: Identification of Novel Prognostic Markers for Breast Cancer, Cancer Research, vol.64, issue.9, pp.3037-3045, 2004.
DOI : 10.1158/0008-5472.CAN-03-2028

M. Demers, A. Rose, A. Grosset, K. Biron-pain, and L. Gaboury, Overexpression of Galectin-7, A Myoepithelial Cell Marker, Enhances Spontaneous Metastasis of Breast Cancer Cells, The American Journal of Pathology, vol.176, issue.6, pp.3023-3031, 2010.
DOI : 10.2353/ajpath.2010.090876

URL : https://hal.archives-ouvertes.fr/pasteur-00819591

R. Pal, M. Janz, D. Galson, M. Gries, and S. Li, C/EBP?? regulates transcription factors critical for proliferation and survival of multiple myeloma cells, Blood, vol.114, issue.18, pp.3890-3898, 2009.
DOI : 10.1182/blood-2009-01-201111

D. Ramji and P. Foka, CCAAT/enhancer-binding proteins: structure, function and regulation, Biochemical Journal, vol.365, issue.3, pp.561-575, 2002.
DOI : 10.1042/bj20020508

C. Zahnow, CCAAT/enhancer-binding protein ??: its role in breast cancer and associations with receptor tyrosine kinases, Expert Reviews in Molecular Medicine, vol.6, p.12, 2009.
DOI : 10.1073/pnas.012437299

S. Zhu, K. Yoon, E. Sterneck, P. Johnson, and R. Smart, CCAAT/enhancer binding protein-?? is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling, Proceedings of the National Academy of Sciences, vol.99, issue.1, pp.207-212, 2002.
DOI : 10.1073/pnas.012437299

G. Robinson, P. Johnson, L. Hennighausen, and E. Sterneck, The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary??gland, Genes & Development, vol.12, issue.12, pp.1907-1916, 1998.
DOI : 10.1101/gad.12.12.1907

T. Seagroves, S. Krnacik, B. Raught, J. Gay, and B. Burgess-beusse, C/EBPbeta , but not C/EBPalpha , is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary??gland, Genes & Development, vol.12, issue.12, pp.1917-1928, 1998.
DOI : 10.1101/gad.12.12.1917

T. Seagroves, J. Lydon, R. Hovey, B. Vonderhaar, and J. Rosen, C/ EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development, Mol Endocrinol, vol.14, pp.359-368, 2000.
DOI : 10.1210/me.14.3.359

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.326.5061

L. Bundy and L. Sealy, CCAAT/enhancer binding protein beta (C/EBP??)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture, Oncogene, vol.22, issue.6, pp.869-883, 2003.
DOI : 10.1038/sj.onc.1206216

A. Mourskaia, Z. Dong, S. Ng, M. Banville, J. Zwaagstra et al., Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone, J Biol Chem, vol.28, pp.1005-1015, 2009.

C. Zahnow, R. Cardiff, R. Laucirica, D. Medina, and J. Rosen, A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation, Cancer Res, vol.61, pp.261-269, 2001.

J. Chen, Q. He, A. Yuen, and J. Chiu, Proteomics of buccal squamous cell carcinoma: The involvement of multiple pathways in tumorigenesis, PROTEOMICS, vol.4, issue.8, pp.2465-2475, 2004.
DOI : 10.1002/pmic.200300762

V. Daniel, L. Marchionni, J. Hierman, J. Rhodes, and W. Devereux, A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro, Cancer Research, vol.69, issue.8, pp.3364-3373, 2009.
DOI : 10.1158/0008-5472.CAN-08-4210

M. Demers, K. Biron-pain, J. Hebert, A. Lamarre, and T. Magnaldo, Galectin-7 in Lymphoma: Elevated Expression in Human Lymphoid Malignancies and Decreased Lymphoma Dissemination by Antisense Strategies in Experimental Model, Cancer Research, vol.67, issue.6, pp.2824-2829, 2007.
DOI : 10.1158/0008-5472.CAN-06-3891

Y. Matsui, S. Ueda, J. Watanabe, I. Kuwabara, and O. Ogawa, Sensitizing Effect of Galectin-7 in Urothelial Cancer to Cisplatin through the Accumulation of Intracellular Reactive Oxygen Species, Cancer Research, vol.67, issue.3, pp.1212-1220, 2007.
DOI : 10.1158/0008-5472.CAN-06-3283

S. Rorive, B. Eddafali, S. Fernandez, C. Decaestecker, and S. Andre, Changes in Galectin-7 and Cytokeratin-19 Expression during the Progression of Malignancy in Thyroid Tumors: Diagnostic and Biological Implications, Modern Pathology, vol.15, issue.12, pp.1294-1301, 2002.
DOI : 10.1097/01.MP.0000037306.19083.28

X. Zhu, M. Ding, M. Yu, M. Feng, and L. Tan, Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis, BMC Cancer, vol.13, issue.2, p.290, 2010.
DOI : 10.1038/sj.onc.1206631

S. Gruvberger, M. Ringner, Y. Chen, S. Panavally, and L. Saal, Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns, Cancer Res, vol.61, pp.5979-5984, 2001.

X. Ma, S. Dahiya, E. Richardson, M. Erlander, and D. Sgroi, Gene expression profiling of the tumor microenvironment during breast cancer progression, Breast Cancer Research, vol.14, issue.1, p.7, 2009.
DOI : 10.1038/nm1764

A. Richardson, Z. Wang, D. Nicolo, A. Lu, X. Brown et al., X chromosomal abnormalities in basal-like human breast cancer, Cancer Cell, vol.9, issue.2, pp.121-132, 2006.
DOI : 10.1016/j.ccr.2006.01.013

A. Minn, G. Gupta, P. Siegel, P. Bos, and W. Shu, Genes that mediate breast cancer metastasis to lung, Nature, vol.436, issue.7050, pp.518-524, 2005.
DOI : 10.1038/nature03799

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1283098

C. Schuetz, M. Bonin, S. Clare, K. Nieselt, and K. Sotlar, Progression-Specific Genes Identified by Expression Profiling of Matched Ductal Carcinomas In situ and Invasive Breast Tumors, Combining Laser Capture Microdissection and Oligonucleotide Microarray Analysis, Cancer Research, vol.66, issue.10, pp.5278-5286, 2006.
DOI : 10.1158/0008-5472.CAN-05-4610

S. Zhu, H. Oh, M. Shim, E. Sterneck, P. Johnson et al., C/EBP?? Modulates the Early Events of Keratinocyte Differentiation Involving Growth Arrest and Keratin 1 and Keratin 10 Expression, Molecular and Cellular Biology, vol.19, issue.10, pp.7181-7190, 1999.
DOI : 10.1128/MCB.19.10.7181

E. Schwartz, M. Reginato, D. Shao, S. Krakow, and M. Lazar, Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription., Molecular and Cellular Biology, vol.17, issue.3, pp.1552-1561, 1997.
DOI : 10.1128/MCB.17.3.1552

N. Wiper-bergeron, C. St-louis, and J. Lee, CCAAT/Enhancer Binding Protein ?? Abrogates Retinoic Acid-Induced Osteoblast Differentiation via Repression of Runx2 Transcription, Molecular Endocrinology, vol.21, issue.9, pp.2124-2135, 2007.
DOI : 10.1210/me.2006-0452

T. Magnaldo, F. Bernerd, and M. Darmon, Galectin-7, a Human 14-kDa S-Lectin, Specifically Expressed in Keratinocytes and Sensitive to Retinoic Acid, Developmental Biology, vol.168, issue.2, pp.259-271, 1995.
DOI : 10.1006/dbio.1995.1078

E. Eaton, M. Hanlon, L. Bundy, and L. Sealy, Characterization of C/EBP? isoforms in normal versus neoplastic mammary epithelial cells, Journal of Cellular Physiology, vol.89, issue.1, pp.91-105, 2001.
DOI : 10.1002/jcp.1139

C. Zahnow, P. Younes, R. Laucirica, and J. Rosen, Overexpression of C/ EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer, J Natl Cancer Inst, vol.89, pp.1887-91, 1997.

K. Milde-langosch, T. Löning, M. Bamberger, A. M. Loning, and . Bamberger, Expression of the CCAAT/Enhancer-Binding Proteins C/EBP??, C/EBP?? and C/EBP?? in Breast Cancer: Correlations with Clinicopathologic Parameters and Cell-Cycle Regulatory Proteins, Breast Cancer Research and Treatment, vol.86, issue.2, pp.175-85, 2003.
DOI : 10.1023/A:1023929504884

C. Campion, M. Labrie, G. Lavoie, and Y. St-pierre, Expression of Galectin-7 Is Induced in Breast Cancer Cells by Mutant p53, PLoS ONE, vol.77, issue.8, p.72468, 2013.
DOI : 10.1371/journal.pone.0072468.s005

URL : https://hal.archives-ouvertes.fr/pasteur-01130355